Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of LEXX will decline by -25.21% over the next 2 Weeks and hit $0.45 by Wednesday, June 3, 2026. In that time frame, LEXX's share price is expected to range between $0.32 and $0.59.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Jun 1, 2026 | 0.41 | 0.50 | 0.58 |
LEXX shares rose +7.13% in Friday, May 22, 2026's trading session, rising from a previous close of $0.61 to move at $0.65. The stock demonstrated notable intraday movement (see LEXX's key stats for a full breakdown), fluctuating between $0.61 and $0.68, a +11.17% trading range. While recent weeks have seen some volatility, LEXX has managed to secure a +6.40% gain over the past 2 weeks. The upward price movement was accompanied by decreased trading volume, with approximately 106.81K shares changing hands, 35.73K fewer than the previous session. This amounted to $69.30K in total market activity.
Will LEXX Continue Its Downward Trend?
According to analyst ratings and projections for LEXX, Lexaria Bioscience Corp. shares are anticipated to decrease by -12.32%, potentially reaching $0.58 per share by June 1, 2026. Short-term technical indicators for LEXX currently suggest a bearish sentiment. This aligns with the stock's recent performance, as it has recorded 17 negative trading days within the past 30 sessions. Based on the LEXX stock forecast, now is not the best time to buy LEXX stock because its current trading price is +30.31% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on LEXX covering social and institutional perspectives.
LEXX Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into LEXX's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 43.23% to 47.71%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 45.95%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 46.76%, maintains a neutral outlook for the long term. Insights into LEXX's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Lexaria Bioscience Short-Term Forecasts
LEXX Forecast For Next 5 Days
Our algorithm anticipates Lexaria Bioscience (LEXX) stock could hit $0.56 by May 29, 2026. This represents a -13.39% fall from today's price, following a -4.44% change over the past five days.
LEXX Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Lexaria Bioscience Corp. (LEXX) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $0.57, which would mean a -12.15% decrease from the current price of $0.65. Projections for this period range from a high of $0.84 to a low of $0.27.
LEXX Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Lexaria Bioscience's price over the next three months point to a rise. LEXX stock is expected to peak at $3.58 on Aug 21, 2026 after potentially dipping to $2.24 on Jul 03, 2026. On average, LEXX is likely to trade around $2.90 in the coming 90 days.
Lexaria Bioscience Stock Forecast 2025
Based on our predictive models, Lexaria Bioscience (LEXX) is expected to trade between $1.16 and $4.26 throughout 2026. This would result in an average price of $3.04, potentially offering investors a +368.56% return from current levels.
Lexaria Bioscience Corp. Monthly Forecast 2026–2027
May 2026
According to our latest forecast models, Lexaria Bioscience Corp. (LEXX) is positioned to show a strong performance in May 2026. The price is predicted to move between $2.48 and $3.15, settling at an average of $2.89. This could translate to a +345.44% gain.
June 2026
Based on current market signals, Lexaria Bioscience Corp. is projected to trend june 2026. We forecast a trading range from $2.27 to $3.38, with a likely average price of $3.04. Investors could expect a potential return of +368.56%.
July 2026
Our predictive algorithms indicate Lexaria Bioscience Corp. stock may see a shift in July 2026. The expected range spans $2.24–$3.14, with an average target of $2.70. This represents a positive outlook and a possible gain of +316.15%.
August 2026
Analyzing established trends, Lexaria Bioscience Corp. looks set to move in August 2026. Projections place the stock between $2.57 and $4.01, averaging around $3.23. This suggests a +397.84% gain from current levels.
September 2026
Market indicators suggest Lexaria Bioscience Corp. could experience notable changes during September 2026. Prices could fluctuate within $2.78 to $4.26, with a midpoint forecast of $3.84. The stock might deliver a +491.86% gain.
October 2026
Forecasting for October 2026, models estimate that Lexaria Bioscience Corp. may undergo key fluctuations. If trends hold, the stock might trade between $2.07 and $3.23, averaging $2.87. This signals a positive trajectory with potential returns around +342.36%.
November 2026
According to our latest forecast models, Lexaria Bioscience Corp. (LEXX) is positioned to show a strong performance in November 2026. The price is predicted to move between $1.93 and $3.16, settling at an average of $3.00. This could translate to a +362.39% gain.
December 2026
Based on current market signals, Lexaria Bioscience Corp. is projected to trend december 2026. We forecast a trading range from $1.16 to $2.94, with a likely average price of $2.70. Investors could expect a potential return of +316.15%.
January 2027
Our predictive algorithms indicate Lexaria Bioscience Corp. stock may see a shift in January 2027. The expected range spans $0.86–$2.68, with an average target of $2.64. This represents a positive outlook and a possible gain of +306.91%.
February 2027
Analyzing established trends, Lexaria Bioscience Corp. looks set to move in February 2027. Projections place the stock between $0.28 and $2.32, averaging around $2.56. This suggests a +294.57% gain from current levels.
March 2027
Market indicators suggest Lexaria Bioscience Corp. could experience notable changes during March 2027. Prices could fluctuate within $0.00 to $2.15, with a midpoint forecast of $2.57. The stock might deliver a +296.12% gain.
April 2027
Forecasting for April 2027, models estimate that Lexaria Bioscience Corp. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $1.84, averaging $2.43. This signals a positive trajectory with potential returns around +274.54%.
May 2027
According to our latest forecast models, Lexaria Bioscience Corp. (LEXX) is positioned to show a strong performance in May 2027. The price is predicted to move between $0.00 and $1.24, settling at an average of $2.00. This could translate to a +208.26% gain.
LEXX's history of dividends and stock splits also plays a role in long-term investor confidence.